• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性乳腺癌或前列腺癌患者骨骼相关事件的医院资源利用和治疗成本:对葡萄牙国家卫生系统的估计。

Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System.

机构信息

Exigo Consultores, Alhos Vedros, Portugal.

出版信息

Value Health. 2011 Jun;14(4):499-505. doi: 10.1016/j.jval.2010.11.014. Epub 2011 May 19.

DOI:10.1016/j.jval.2010.11.014
PMID:21669375
Abstract

BACKGROUND

Skeletal-related events (SREs) occur frequently in patients with bone metastases as a result of breast (BC) and prostate (PC) cancers. They increase both morbidity and mortality and lead to extensive health-care resource utilization.

METHODS

Health care resource utilization by BC/PC patients with at least one SRE during the preceding 12 months was assessed through retrospective chart review. SRE-treatment costs were estimated using the Portuguese Ministry of Health cost database and analyzed using generalized linear models.

RESULTS

This study included 152 patients from nine hospitals. The mean (SD) annual SRE-treatment cost per patient was €5963 (€3646) and €5711 (€4347), for BC (n=121) and PC (n=31) patients, respectively. Mean cost per single episode ranged between €1485 (radiotherapy) and €13,203 (spinal cord compression). Early onset of bone metastasis (P = 0.03) and diagnosis of bone metastases at or after the occurrence of the first SRE (P < 0.001) were associated with higher SRE-treatment costs.

CONCLUSION

These results reveal the high hospital SRE-treatment costs, highlighting the need for early diagnosis and treatment, and identify key factors determining the economic value of therapies for patients with skeletal metastases.

摘要

背景

由于乳腺癌(BC)和前列腺癌(PC),骨转移患者经常发生骨骼相关事件(SREs)。这些事件增加了发病率和死亡率,并导致大量医疗资源的利用。

方法

通过回顾性图表审查,评估了在过去 12 个月中至少发生一次 SRE 的 BC/PC 患者的医疗资源利用情况。使用葡萄牙卫生部的成本数据库来估计 SRE 治疗费用,并使用广义线性模型进行分析。

结果

本研究纳入了来自 9 家医院的 152 名患者。BC(n=121)和 PC(n=31)患者的年 SRE 治疗费用分别为每位患者 5963 欧元(5663 欧元)和 5711 欧元(4347 欧元)。每次 SRE 治疗费用的平均值在 1485 欧元(放疗)和 13203 欧元(脊髓压迫)之间。骨转移的早期发病(P=0.03)和首次 SRE 发生时或之后诊断为骨转移(P<0.001)与更高的 SRE 治疗费用相关。

结论

这些结果揭示了医院 SRE 治疗费用高昂,突出了早期诊断和治疗的必要性,并确定了决定骨骼转移患者治疗经济价值的关键因素。

相似文献

1
Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System.转移性乳腺癌或前列腺癌患者骨骼相关事件的医院资源利用和治疗成本:对葡萄牙国家卫生系统的估计。
Value Health. 2011 Jun;14(4):499-505. doi: 10.1016/j.jval.2010.11.014. Epub 2011 May 19.
2
The cost of treating skeletal-related events in patients with prostate cancer.前列腺癌患者骨骼相关事件的治疗成本。
Am J Manag Care. 2008 May;14(5):317-22.
3
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice.对典型临床实践中所见的乳腺癌骨转移患者骨骼并发症对总医疗费用影响的回顾性研究。
J Support Oncol. 2006 Jul-Aug;4(7):341-7.
4
Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases.与前列腺癌伴骨转移患者骨骼相关事件相关的医疗保健利用和费用。
Prostate Cancer Prostatic Dis. 2013 Mar;16(1):23-7. doi: 10.1038/pcan.2012.42. Epub 2012 Nov 13.
5
Canadian health care institution resource utilization resulting from skeletal-related events.与骨骼相关事件导致的加拿大医疗保健机构资源利用情况。
Hosp Pract (1995). 2014 Feb;42(1):15-22. doi: 10.3810/hp.2014.02.1087.
6
Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients.前列腺癌患者骨骼相关事件治疗的经济学评估
Value Health. 2018 Mar;21(3):304-309. doi: 10.1016/j.jval.2017.02.008. Epub 2017 Sep 21.
7
Skeletal-related events among breast and prostate cancer patients: towards new treatment initiation in Malaysia's hospital setting.
Asian Pac J Cancer Prev. 2013;14(5):3357-62. doi: 10.7314/apjcp.2013.14.5.3357.
8
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.原发性乳腺癌患者脑转移的流行病学与经济负担:来自美国索赔数据分析的结果
Breast Cancer Res Treat. 2008 Mar;108(2):297-305. doi: 10.1007/s10549-007-9601-0. Epub 2007 Jun 19.
9
Costs of prostate cancer, metastatic to the bone, in the Netherlands.荷兰前列腺癌骨转移的费用。
Eur Urol. 2003 Mar;43(3):226-32. doi: 10.1016/s0302-2838(03)00007-1.
10
New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.新一代双膦酸盐:在乳腺癌和前列腺癌中的广泛临床应用
Oncology (Williston Park). 2004 May;18(5 Suppl 3):26-32.

引用本文的文献

1
Prevention and Co-Management of Breast Cancer-Related Osteoporosis Using Resveratrol.利用白藜芦醇预防和共同管理乳腺癌相关骨质疏松症。
Nutrients. 2024 Feb 29;16(5):708. doi: 10.3390/nu16050708.
2
COSTS ANALYSIS OF SPINAL COLUMN METASTASES SURGICAL TREATMENT.脊柱转移瘤手术治疗的成本分析
Acta Ortop Bras. 2022 Dec 2;30(spe2):e251579. doi: 10.1590/1413-785220223002e251579. eCollection 2022.
3
Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events.
实体瘤骨转移且无骨靶向药物治疗史患者的医疗资源利用情况及相关费用:有和无骨骼相关事件患者的对比分析。
Eur J Health Econ. 2021 Mar;22(2):243-254. doi: 10.1007/s10198-020-01247-z. Epub 2021 Jan 18.
4
Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017.基于2015年至2017年国家医疗保险数据库的中国前列腺癌患者医疗服务利用情况及费用
Front Pharmacol. 2020 Jun 10;11:719. doi: 10.3389/fphar.2020.00719. eCollection 2020.
5
Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis.新诊断为转移性前列腺癌男性的就医情况及骨相关事件的发生时间:一项队列分析。
Urol Oncol. 2018 Jul;36(7):340.e23-340.e31. doi: 10.1016/j.urolonc.2018.03.023. Epub 2018 May 1.
6
Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study.八个欧洲国家与骨骼辐射相关的医疗资源利用情况:一项回顾性研究的结果
J Bone Oncol. 2018 Feb 5;10:49-56. doi: 10.1016/j.jbo.2018.01.003. eCollection 2018 Mar.
7
Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data.乳腺癌患者骨转移和骨相关事件(SREs)的发病率、危险因素及预后特征:基于真实世界数据的系统评价
J Bone Oncol. 2018 Feb 3;11:38-50. doi: 10.1016/j.jbo.2018.01.004. eCollection 2018 Jun.
8
Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries.病理性骨折与医疗资源利用:一项在八个欧洲国家开展的回顾性研究。
J Bone Oncol. 2016 Sep 12;5(4):185-193. doi: 10.1016/j.jbo.2016.07.003. eCollection 2016 Nov.
9
Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer.生成去势抵抗性前列腺癌相关成本和利用率方面的挑战。
J Mark Access Health Policy. 2014 Jul 4;2. doi: 10.3402/jmahp.v2.24072. eCollection 2014.
10
Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countries.骨转移患者骨相关事件的卫生资源利用情况:一项多国回顾性-前瞻性观察性研究的结果——来自4个欧洲国家的队列研究
J Bone Oncol. 2014 May 9;3(2):40-8. doi: 10.1016/j.jbo.2014.04.001. eCollection 2014 May.